Date | Title |
---|---|
08 Mar 2023 |
IP Group plc |
21 Feb 2023 |
IP Group plc Australian portfolio company AMSL Aero’s all-electric aircraft takes maiden flight |
16 Feb 2023 |
IP Group plc |
30 Jan 2023 |
IP Group plc |
18 Jan 2023 |
IP Group plc |
11 Jan 2023 |
IP Group plc |
05 Dec 2022 |
IP Group plc Portfolio company Istesso announces FDA Fast Track and Orphan Drug designation for MBS2320 |
02 Dec 2022 |
IP Group plc Portfolio company funding round leads to £36m net fair value gain |
15 Nov 2022 |
IP Group plc Becomes most active investor in Australian university spin-outs |
31 Aug 2022 |
IP Group plc Portfolio company Istesso announces initiation of Phase 2b trial of lead drug MBS2320 |
Loadmore